APA

Patti F., Amato M. P., Bastianello S., Caniatti L., Di Monte E., Ferrazza P., Goretti B., Gallo P., Morra V. B., Lo Fermo S., Picconi O., Tola M. R. & Trojano M. (20100308). Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Patti F, Amato M P, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra V Brescia, Lo Fermo S, Picconi O, Tola M R and Trojano M. 20100308. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Patti F., Amato M. P., Bastianello S., Caniatti L., Di Monte E., Ferrazza P., Goretti B., Gallo P., Morra V. B., Lo Fermo S., Picconi O., Tola M. R. and Trojano M. (20100308). Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Patti F, Amato M P, Bastianello S, Caniatti L, Di Monte E, Ferrazza P, Goretti B, Gallo P, Morra V Brescia, Lo Fermo S, Picconi O, Tola M R and Trojano M. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. : Multiple sclerosis (Houndmills, Basingstoke, England). 20100308.